Martin Gelbke, MD
Adult Reconstructive Orthopaedic Surgery · Bozeman, MTNPI 1932324860
Payments from drug & device makers
Across 67 payments — averaging $120.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Shalby Advanced Technologies, Inc.$1K
- Zimmer Biomet$773
- Stryker$662
- Medacta USA, Inc.$194
- Johnson & Johnson$185
- plus $870 from 11 others
What the payments were for
- Consulting fees$1,95824%
- Travel & lodging$2,21627%
- Food & beverage$3,91648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 19 | $4,288 |
| Shalby Advanced Technologies, Inc. | 4 | $1,119 |
| Zimmer Biomet | 8 | $773 |
| Stryker | 6 | $662 |
| Medacta USA, Inc. | 2 | $194 |
| Johnson & Johnson | 3 | $185 |
| Pacira Pharmaceuticals Incorporated | 6 | $156 |
| Restor3d, Inc. | 1 | $144 |
| Microport Orthopedics Inc | 1 | $117 |
| Trimed, Inc. | 1 | $86 |
| Sioux Surgical Inc | 4 | $83 |
| Baxter Healthcare | 2 | $79 |
| Ferring Pharmaceuticals Inc. | 4 | $67 |
| Pacira Therapeutics, Inc. | 2 | $49 |
| Vericel Corporation | 2 | $47 |
| Acera Surgical, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$4,100
- CKS- Vitalite$2,085
- CONSENSUS KNEE SYSTEM$2,085
- RI.HIP NAVIGATION$1,460
- Legion Revision$1,358
- OR3O Dual Mobility$1,358
- JOURNEY$1,358
- Journey II BCS$1,208
- Journey II CR$1,208
- LEGION TKS$1,208
- VISIONAIRE FastPak$1,208
- PRO$490
- Persona$298
- REAL INTELLIGENCE$279
- ROSA$244
- CORI$236
- Journey II XR$134
- PELVIS II$118
- AXSOS$118
- MPO Medial Pivot Knee$117
How this compares
Too few adult reconstructive orthopaedic surgery providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 69 | $21,393 |
| Celecoxib | 337 | $6,420 |
| Hydromorphone Hcl | 130 | $895 |
| Methocarbamol | 95 | $342 |
| Amoxicillin | 151 | $221 |
| Oxycodone Hcl | 32 | $209 |
| Clindamycin Hcl | 24 | $73 |
| Ondansetron OdtOndansetron | 13 | $52 |
| Tramadol Hcl | 15 | $27 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Bozeman
- Dean SukinBozeman$337K
- Daniel GannonBozeman$13K
- Michael GrooverBillings$54K
- David AllmacherMissoula$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.